BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 278177)

  • 1. Influence of proquazone (Biarison) on the levels of complement components (C3 and C4) in synovial fluid and on IgM in serum in patients with active rheumatoid arthritis. A preliminary report.
    Skrifvars B
    Scand J Rheumatol Suppl; 1978; (21):40-2. PubMed ID: 278177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
    Stojan B
    Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of immunoglobulins and complement factors in synovial fluid and serum in rheumatoid arthritis, seronegative spondyloarthropathies and osteoarthritis: pathophysiology and retrospective analysis of clinical value].
    Möller B; Kessler U; Braner A; Dielehner N; Kaltwasser JP
    Z Rheumatol; 2002 Feb; 61(1):48-57. PubMed ID: 11974492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological effects of Biarison in the treatment of rheumatoid arthritis and systemic lupus erythematosus. A preliminary report.
    Skrifvars B; Nissilä M
    Scand J Rheumatol; 1980; 9(1):33-8. PubMed ID: 7375869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
    Biró E; Nieuwland R; Tak PP; Pronk LM; Schaap MC; Sturk A; Hack CE
    Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathological changes in rheumatoid arthritis and other joint diseases.
    Ghose T; Woodbury JF; Ahmad S; Stevenson B
    J Clin Pathol; 1975 Feb; 28(2):109-17. PubMed ID: 1092716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activated C3 in the synovial fluid of patients with rheumatoid arthritis and arthrosis (correlations with C3, C4 and C3 proactivator/modification caused by storage)].
    Hasler F; Stojan B
    Z Rheumatol; 1981; 40(1):40-3. PubMed ID: 6908792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlations between inflammatory activity, immunoglobulins and complement components in the synovial fluid of patients with rheumatoid arthritis and arthrosis].
    Stojan B; Hasler F
    Schweiz Med Wochenschr; 1978 Jul; 108(30):1165-8. PubMed ID: 675210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis.
    Perrin LH; Nydegger UE; Zubler RH; Lambert PH; Miescher PA
    Arthritis Rheum; 1977 Mar; 20(2):647-52. PubMed ID: 849359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.
    Westedt ML; Daha MR; de Vries E; Valentijn RM; Cats A
    J Rheumatol; 1985 Jun; 12(3):449-55. PubMed ID: 4045842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of the immunological tests in rheumatoid arthritis.
    Kim NH; Yang KH; Yang IH
    Yonsei Med J; 1989; 30(1):23-9. PubMed ID: 2741472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
    Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement and immunoglobulins in synovial fluid from synovectomized patients with rheumatoid arthritis.
    Mellbye OJ; Naes B; Munthe E
    Ann Rheum Dis; 1976 Jun; 35(3):233-9. PubMed ID: 825053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum immunoglobulin patterns in rheumatoid arthritis].
    Dreher R
    Z Rheumatol; 1977; 36(1-2):3-21. PubMed ID: 842145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of complement-fixing rheumatoid synovial fluid immune complexes.
    Male DK; Roitt IM
    Clin Exp Immunol; 1981 Dec; 46(3):521-9. PubMed ID: 7337979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic evaluation of rheumatoid arthritis and therapy with levamisole.
    Verhaegen H; de Cree J; de Cock W; Schuermans Y; Engels M; Sonck W
    Biomedicine; 1977 Jul; 26(4):283-91. PubMed ID: 922113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of synovial fluid analysis in estimating the efficacy of intra-articular corticosteroid injections in patients with rheumatoid arthritis.
    Luukkainen R; Hakala M; Sajanti E; Huhtala H; Yli-Kerttula U; Hämeenkorpi R
    Ann Rheum Dis; 1992 Jul; 51(7):874-6. PubMed ID: 1632661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial fluid in seronegative juvenile rheumatoid arthritis: studies of immunoglobulins, complements, and alpha 2-macroglobulin.
    Martin CL; Pachman LM
    Arthritis Rheum; 1980 Nov; 23(11):1256-61. PubMed ID: 6160859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological comparison of patients with rheumatoid arthritis with and without nephropathy.
    Korpela M; Mustonen J; Helin H; Pasternack A
    Ann Rheum Dis; 1990 Apr; 49(4):214-8. PubMed ID: 2339901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.